Home | Investors | ASX Announcements | 2019 ASX Announcements 2019 Date Document 03/12/2019 Change of Director's Interest Notice x 4 03/12/2019 Appendix 3B and Secondary Trading Notice 28/11/2019 Results of Meeting 28/11/2019 Resonance Health Partners with Siemens healthineers 25/11/2019 Investor Presentation November 2019 21/11/2019 New AI Tool for Automated Assessment of Liver Fat 20/11/2019 Resonance Health Files Provisional Patent 28/10/2019 Appendix 4C - quarterly 25/10/2019 Notice of Annual General Meeting/Proxy Form 22/10/2019 Updated Securities Trading Policy 22/10/2019 Annual Report to shareholders 22/10/2019 Appendix 4G and Corporate Governance Statement 27/09/2019 Full Year Statutory Accounts 27/08/2019 Preliminary Final Report 29/07/2019 Appendix 4C - quarterly 19/07/2019 Resonance Health contracted new clinical trials 16/07/2019 Appendix 3B and Secondary Trading Notice 01/05/2019 Secondary Trading Notice 30/04/2019 R&D Activities Update and Appendix 3B 16/04/2019 Customer Newsletter - April 2019 16/04/2019 Appendix 4C - quarterly 15/04/2019 Response to ASX Price and Volume Query 25/03/2019 Investor Presentation March 2019 25/02/2019 Half Yearly Report and Accounts 05/02/2019 Change of Director's Interest Notice 21/01/2019 Appendix 4C - quarterly 15/01/2019 Execution of Distribution Agreement with EnvoyAI 03/01/2019 Execution of License Agreement
